Pediatric Bipolar Disorder
7
1
1
1
Key Insights
Highlights
Success Rate
25% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
42.9%
3 terminated out of 7 trials
25.0%
-61.5% vs benchmark
43%
3 trials in Phase 3/4
300%
3 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Greater Houston Area Pediatric Bipolar Registry
Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
Screening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum Disorder
Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
Omega 3 Fatty Acid Trial